Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

NYSE:SQNS - New York Stock Exchange, Inc. - US8173233060 - ADR - Currency: USD

2.7  -0.27 (-9.09%)

Premarket: 2.8 +0.1 (+3.7%)

Fundamental Rating

3

SQNS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. There are concerns on the financial health of SQNS while its profitability can be described as average. SQNS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SQNS had positive earnings in the past year.
SQNS had a negative operating cash flow in the past year.
SQNS had negative earnings in 4 of the past 5 years.
In the past 5 years SQNS always reported negative operating cash flow.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of SQNS (63.09%) is better than 100.00% of its industry peers.
SQNS's Return On Equity of 126.18% is amongst the best of the industry. SQNS outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 63.09%
ROE 126.18%
ROIC N/A
ROA(3y)2.49%
ROA(5y)-15.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

The Profit Margin of SQNS (159.12%) is better than 100.00% of its industry peers.
The Gross Margin of SQNS (74.83%) is better than 94.55% of its industry peers.
SQNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 159.12%
GM 74.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

More info and screens

2

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQNS has been increased compared to 1 year ago.
Compared to 5 years ago, SQNS has more shares outstanding
Compared to 1 year ago, SQNS has an improved debt to assets ratio.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that SQNS is in the distress zone and has some risk of bankruptcy.
SQNS's Altman-Z score of 1.31 is on the low side compared to the rest of the industry. SQNS is outperformed by 70.00% of its industry peers.
SQNS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SQNS (0.00) is better than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC13.61%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

SQNS has a Current Ratio of 1.95. This is a normal value and indicates that SQNS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.95, SQNS is not doing good in the industry: 77.27% of the companies in the same industry are doing better.
SQNS has a Quick Ratio of 1.87. This is a normal value and indicates that SQNS is financially healthy and should not expect problems in meeting its short term obligations.
SQNS's Quick ratio of 1.87 is on the low side compared to the rest of the industry. SQNS is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.87
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

SQNS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.34%, which is quite impressive.
Looking at the last year, SQNS shows a very strong growth in Revenue. The Revenue has grown by 40.03%.
SQNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.60% yearly.
EPS 1Y (TTM)260.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.43%
Revenue 1Y (TTM)40.03%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%33.63%

3.2 Future

The Earnings Per Share is expected to decrease by -46.45% on average over the next years. This is quite bad
SQNS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.64% yearly.
EPS Next Y-142.52%
EPS Next 2Y-46.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.51%
Revenue Next 2Y31.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.14 indicates a rather cheap valuation of SQNS.
SQNS's Price/Earnings ratio is rather cheap when compared to the industry. SQNS is cheaper than 100.00% of the companies in the same industry.
SQNS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.54.
The Forward Price/Earnings Ratio is negative for SQNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 1.14
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A cheap valuation may be justified as SQNS's earnings are expected to decrease with -46.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.45%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SQNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (7/18/2025, 8:13:31 PM)

Premarket: 2.8 +0.1 (+3.7%)

2.7

-0.27 (-9.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-21 2025-08-21/bmo
Inst Owners65.48%
Inst Owner Change0%
Ins Owners5.9%
Ins Owner ChangeN/A
Market Cap68.90M
Analysts82.86
Price Target7.65 (183.33%)
Short Float %31.77%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.41%
Min EPS beat(2)-12.04%
Max EPS beat(2)18.86%
EPS beat(4)3
Avg EPS beat(4)221.85%
Min EPS beat(4)-12.04%
Max EPS beat(4)860.78%
EPS beat(8)5
Avg EPS beat(8)103.84%
EPS beat(12)8
Avg EPS beat(12)87.2%
EPS beat(16)12
Avg EPS beat(16)72.28%
Revenue beat(2)2
Avg Revenue beat(2)6.09%
Min Revenue beat(2)2.52%
Max Revenue beat(2)9.67%
Revenue beat(4)4
Avg Revenue beat(4)33.79%
Min Revenue beat(4)2.52%
Max Revenue beat(4)105.88%
Revenue beat(8)4
Avg Revenue beat(8)3.77%
Revenue beat(12)5
Avg Revenue beat(12)1.92%
Revenue beat(16)5
Avg Revenue beat(16)0.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.85%
EPS NY rev (1m)-2.17%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.46%
Revenue NY rev (3m)-3.65%
Valuation
Industry RankSector Rank
PE 1.14
Fwd PE N/A
P/S 1.77
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)2.37
EY87.78%
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-1.39
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS1.52
BVpS1.96
TBVpS1.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 63.09%
ROE 126.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 159.12%
GM 74.83%
FCFM N/A
ROA(3y)2.49%
ROA(5y)-15.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 140.21%
Cap/Sales 24.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.87
Altman-Z 1.31
F-Score6
WACC13.61%
ROIC/WACCN/A
Cap/Depr(3y)236.59%
Cap/Depr(5y)224.99%
Cap/Sales(3y)60.32%
Cap/Sales(5y)52.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.43%
EPS Next Y-142.52%
EPS Next 2Y-46.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.03%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%33.63%
Revenue Next Year-5.51%
Revenue Next 2Y31.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-700.69%
OCF growth 3YN/A
OCF growth 5YN/A